Strattera
Product Images NDC 64725-3228

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Strattera (NDC 64725-3228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 3228)

Label for Strattera 25mg capsules, 30 count bottle. The label notes it is Rx only, manufactured by Lilly and repackaged by TYA Pharmaceuticals in Tallahassee, FL. Includes lot number, expiration date fields, a barcode, and instruction to see package insert for dosing.*

FDA Label Image

Chemical Structure (Strattera1)

Chemical structure of atomoxetine hydrochloride, the active ingredient in Strattera by TYA Pharmaceuticals. The structure shows a phenylpropylamine backbone with a methoxy-substituted phenyl ring, another phenyl ring, and a methylamino group associated with hydrochloride.*

FDA Label Image

Figure 1 (Strattera2)

Two line graphs showing the mean weight percentile and mean height percentile over 36 months of treatment for a sample population. The left graph depicts mean weight percentile with N=203, indicating slight fluctuations and a general upward trend toward the end. The right graph shows mean height percentile with N=155, remaining relatively stable over time with minor variation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.